Clinical Trials Directory

Trials / Unknown

UnknownNCT03882775

Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction

Bivalirudin vs Heparin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
The First Affiliated Hospital of Dalian Medical University · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

The study is an investigator-sponsored, prospective, multicenter, randomized, open-label study designed to compare efficacy and safety between bivalirudin and heparin in elderly patients with acute ST-segment elevation myocardial infarction undergoing emergency PCI.

Conditions

Interventions

TypeNameDescription
DRUGBivalirudinPatients would be given anticoagulant therapy with bivalirudin in acute STEMI during emergency PCI operation.
DRUGHeparinheparin with or without gpi during emergency PCI.

Timeline

Start date
2019-01-16
Primary completion
2020-07-14
Completion
2020-12-31
First posted
2019-03-20
Last updated
2019-03-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03882775. Inclusion in this directory is not an endorsement.

Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction (NCT03882775) · Clinical Trials Directory